{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:31:27Z","timestamp":1792427487221,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>With the recent approval of the malaria vaccine by the World Health Organization, it is expected that global acceptance and subsequent uptake of the intervention can help to reduce the burden of the disease in Africa. This study\u00a0adopted a proactive approach in  assessing parents'\u00a0acceptance of the malaria vaccine, alongside their willingness to pay for the\u00a0novel public health intervention.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A national cross-sectional survey was undertaken in Nigeria using a questionnaire as the data collection instrument. The study tool was administered to\u00a0parents of child-bearing\u00a0age. Descriptive and inferential statistical analyses were performed using the Statistical Package for Social Sciences (SPSS) software version 25.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 1413 valid responses were received\u00a0with male\u00a0(49.5%) and female\u00a0(50.5%) participants represented\u00a0by similar proportions. Close to two-thirds (62.5%) of the participants were between the ages of 31 and 40\u00a0years, and 47.4% of the participants were educated up to national diploma level. More than two-thirds (69.6%) of the participants indicated that they were worried about side effects that may be associated with\u00a0the malaria vaccine. A strong majority (90%) of the participants indicated that the vaccine should be administered at no cost to citizens, while 46.7% of the respondents were willing to pay for\u00a0the malaria vaccination. Levels of education\u00a0attained by the respondents influenced their willingness to pay for malaria vaccination. This variable also underpinned participants'\u00a0 reasons for non-acceptance of the vaccine. Those who attained only\u00a0primary and secondary levels of education were significantly more likely to  reject the malaria vaccine because they were against vaccines in general (AOR\u2009=\u20096.63; 95% CI\u2009=\u20091.33 \u2013 39.25; <jats:italic>p<\/jats:italic>\u2009=\u20090.021). <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This study provides critical\u00a0novel insights which could influence vaccination efforts aimed at reducing the burden of malaria in Nigeria, as well as similar settings.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12936-025-05268-y","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T03:25:56Z","timestamp":1738898756000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Acceptance and affordability of malaria vaccines: issues relating to hesitancy and willingness to pay amongst Nigerian parents of under-five children"],"prefix":"10.1186","volume":"24","author":[{"given":"Obi Peter","family":"Adigwe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Godspower","family":"Onavbavba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"key":"5268_CR1","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/joim.12223","volume":"275","author":"C Arama","year":"2014","unstructured":"Arama C, Troye-Blomberg M. The path of malaria vaccine development: challenges and perspectives. J Int Med. 2014;275:456\u201366.","journal-title":"J Int Med"},{"key":"5268_CR2","doi-asserted-by":"publisher","first-page":"1017024","DOI":"10.1016\/S0140-6736(04)15836-4","volume":"363","author":"B Singh","year":"2004","unstructured":"Singh B, Kim SL, Matusop A, Radhakrishnan A, Shamsul SS, Cox-Singh J, et al. A large focus of naturally acquired Plasmodium knowlesi infections in human beings. Lancet. 2004;363:1017024.","journal-title":"Lancet"},{"key":"5268_CR3","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2147\/CEOR.S299050","volume":"13","author":"Y Wagnew","year":"2021","unstructured":"Wagnew Y, Hagos T, Weldegerima B, Debie A. Willingness to pay for childhood malaria vaccine among caregivers of under-five children in Northwest Ethiopia. Clinicoecon Outcomes Res. 2021;13:165\u201374.","journal-title":"Clinicoecon Outcomes Res"},{"key":"5268_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0278224","volume":"17","author":"SK Sulaiman","year":"2022","unstructured":"Sulaiman SK, Musa MS, Tsiga-Ahmed FI, Dayyab FM, Sulaiman AK, Bako TA. A systematic review and meta-analysis of the prevalence of caregiver acceptance of malaria vaccine for under-five children in low-income and middle-income countries (LMICs)\u2019. PLoS ONE. 2022;17: e0278224.","journal-title":"PLoS ONE"},{"key":"5268_CR5","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.4269\/ajtmh.19-0386","volume":"101","author":"N Sarma","year":"2019","unstructured":"Sarma N, Patouillard E, Cibulskis RE, Arcand JL. The economic burden of malaria: revisiting the evidence. Am J Trop Med Hyg. 2019;101:1405\u201315.","journal-title":"Am J Trop Med Hyg"},{"key":"5268_CR6","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1111\/febs.14127","volume":"284","author":"AM Thu","year":"2017","unstructured":"Thu AM, Phyo AP, Landier J, Parker DM, Nosten FH. Combating multidrug-resistant Plasmodium falciparum malaria. FEBS J. 2017;284:2569\u201378.","journal-title":"FEBS J"},{"key":"5268_CR7","doi-asserted-by":"publisher","first-page":"20130433","DOI":"10.1098\/rstb.2013.0433","volume":"369","author":"B Greenwood","year":"2014","unstructured":"Greenwood B. The contribution of vaccination to global health: past, present and future. Philos Trans R Soc Lond B Biol Sci. 2014;369:20130433.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"5268_CR8","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1016\/j.vaccine.2017.04.034","volume":"35","author":"D Adeloye","year":"2017","unstructured":"Adeloye D, Jacobs W, Amuta AO, Ogundipe O, Mosaku O, Gadanya MA, et al. Coverage and determinants of childhood immunization in Nigeria: a systematic review and meta-analysis. Vaccine. 2017;35:2871\u201381.","journal-title":"Vaccine"},{"key":"5268_CR9","unstructured":"National Primary Health Care Development Agency. Is immunization free in Nigeria?. 2025. Available online: https:\/\/nphcda.gov.ng\/faq\/is-immunization-free-in-nigeria\/ Accessed 8 Jan\u00a02025."},{"key":"5268_CR10","unstructured":"World Bank Group. Nigeria Immunization Financing Assessment. 2018. Available online: https:\/\/documents1.worldbank.org\/curated\/en\/955881615801705759\/pdf\/Nigeria-Immunization-Financing-Assessment.pdf. Accessed 8 Jan 2025."},{"key":"5268_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvacx.2021.100112","volume":"9","author":"OP Adigwe","year":"2021","unstructured":"Adigwe OP. COVID-19 vaccine hesitancy and willingness to pay: emergent factors from a cross-sectional study in Nigeria. Vaccine X. 2021;9: 100112.","journal-title":"Vaccine X"},{"key":"5268_CR12","unstructured":"National Agency for Food and Drug Administration and Control. NAFDAC gives provisional approval for R21 malaria vaccine. 2023. Available online: https:\/\/www.nafdac.gov.ng\/press-briefing-by-prof-mojisola-christianah-adeyeye-director-general-national-agency-for-food-and-drug-administration-and-control-nafdac-on-the-regulatory-approval-of-r21-malaria-vaccine-by-nafdac\/ Accessed 22 July 2023."},{"key":"5268_CR13","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s10654-020-00671-y","volume":"35","author":"AA Dror","year":"2020","unstructured":"Dror AA, Eisenbach N, Taiber S, Morozov NG, Mizrachi M, Zigron A, et al. Vaccine hesitancy: the next challenge in the fight against COVID-19. Eur J Epidemiol. 2020;35:775\u20139.","journal-title":"Eur J Epidemiol"},{"key":"5268_CR14","unstructured":"Premium Times. Hope for millions as Nigeria approves malaria vaccine. 2023. https:\/\/www.premiumtimesng.com\/news\/top-news\/593845-hope-for-millions-as-nigeria-approves-malaria-vaccine.html#:~:text=The%20Nigerian%20government%20has%20approved,the%20Serum%20Institute%20of%20India. Accessed 23 July 2023."},{"key":"5268_CR15","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1080\/21645515.2020.1829315","volume":"17","author":"LR Biasio","year":"2021","unstructured":"Biasio LR, Bonaccorsi G, Lorini C, Pecorelli S. Assessing COVID-19 vaccine literacy: a preliminary online survey. Hum Vaccin Immunother. 2021;17:1304\u201312.","journal-title":"Hum Vaccin Immunother"},{"key":"5268_CR16","volume-title":"Fact sheet about malaria","author":"World Health Organization","year":"2023","unstructured":"World Health Organization. Fact sheet about malaria. Geneva: World Health Organization; 2023."},{"key":"5268_CR17","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1080\/21645515.2018.1459252","volume":"14","author":"HJ Larson","year":"2018","unstructured":"Larson HJ, Clarke RM, Jarrett C, Eckersberger E, Levine Z, Schulz WS, et al. Measuring trust in vaccination: a systematic review. Hum Vaccin Immunother. 2018;14:1599\u2013609.","journal-title":"Hum Vaccin Immunother"},{"key":"5268_CR18","doi-asserted-by":"publisher","first-page":"0360","DOI":"10.1126\/scitranslmed.aat0360","volume":"11","author":"NE Dean","year":"2019","unstructured":"Dean NE, Gsell PS, Brookmeyer R, De Gruttola V, Donnelly CA, Halloran ME, et al. Design of vaccine efficacy trials during public health emergencies. Sci Transl Med. 2019;11:0360.","journal-title":"Sci Transl Med"},{"key":"5268_CR19","doi-asserted-by":"publisher","first-page":"e80","DOI":"10.1016\/S1473-3099(20)30130-4","volume":"20","author":"MZ Dudley","year":"2020","unstructured":"Dudley MZ, Halsey NA, Omer SB, Orenstein WA, O\u2019Leary ST, Limaye RJ, et al. The state of vaccine safety science: systematic reviews of the evidence. Lancet Infect Dis. 2020;20:e80\u20139.","journal-title":"Lancet Infect Dis"},{"key":"5268_CR20","unstructured":"Centre for Disease Control and Prevention. Vaccines & Immunizations. 2020. https:\/\/www.cdc.gov\/vaccines\/vac-gen\/side-effects.htm. Accessed 24 July 2023"},{"key":"5268_CR21","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1186\/s12889-015-2471-1","volume":"15","author":"MU Khan","year":"2015","unstructured":"Khan MU, Ahmad A, Aqeel T, Salman S, Ibrahim Q, Idress J, et al. Knowledge, attitudes and perceptions towards polio immunization among residents of two highly affected regions of Pakistan. BMC Public Health. 2015;15:1100.","journal-title":"BMC Public Health"},{"key":"5268_CR22","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12936-022-04164-z","volume":"21","author":"G Asmare","year":"2022","unstructured":"Asmare G. Willingness to accept malaria vaccine among caregivers of under-5 children in Southwest Ethiopia: a community based cross-sectional study. Malar J. 2022;21:146.","journal-title":"Malar J"},{"key":"5268_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.899","volume":"11","author":"H Mumtaz","year":"2023","unstructured":"Mumtaz H, Nadeem A, Bilal W, Ansar F, Saleem S, Khan QA, et al. Acceptance, availability, and feasibility of RTS, S\/AS01 malaria vaccine: a review. Immun Inflamm Dis. 2023;11: e899.","journal-title":"Immun Inflamm Dis"},{"key":"5268_CR24","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1186\/s12889-024-19267-2","volume":"24","author":"AS Ligeti","year":"2024","unstructured":"Ligeti AS, Oroszi B, Luca C, Bilics E, \u00c1goston J, R\u00f6st G, et al. Socioeconomic determinants and reasons for non-acceptance to vaccination recommendations during the 3rd-5th waves of the COVID-19 pandemic in Hungary. BMC Public Health. 2024;24:1796.","journal-title":"BMC Public Health"},{"key":"5268_CR25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3325\/cmj.2022.63.89","volume":"63","author":"D Bagi\u0107","year":"2022","unstructured":"Bagi\u0107 D, \u0160uljok A, An\u010di\u0107 B. Determinants and reasons for coronavirus disease 2019 vaccine hesitancy in Croatia. Croat Med J. 2022;63:89\u201397.","journal-title":"Croat Med J"},{"key":"5268_CR26","doi-asserted-by":"publisher","first-page":"700","DOI":"10.3390\/vaccines11030700","volume":"11","author":"J Go\u0142\u0119biowska","year":"2023","unstructured":"Go\u0142\u0119biowska J, Zimny-Zaj\u0105c A, Dr\u00f3\u017cd\u017c M, Makuch S, Dudek K, Mazur G, et al. Evaluation of the approach towards vaccination against COVID-19 among the Polish population\u2014In relation to sociodemographic factors and physical and mental health. Vaccines. 2023;11:700.","journal-title":"Vaccines"},{"key":"5268_CR27","first-page":"2","volume":"6","author":"BI Abdulkadir","year":"2015","unstructured":"Abdulkadir BI, Ajayi IO. Willingness to accept malaria vaccine among caregivers of under-5 children in Ibadan North Local Government Area. Nigeria Malarworld J. 2015;6:2.","journal-title":"Nigeria Malarworld J"},{"key":"5268_CR28","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13104-019-4085-7","volume":"12","author":"AA Tarekegn","year":"2019","unstructured":"Tarekegn AA, Yismaw AE. Health professionals\u2019 willingness to pay and associated factors for human papilloma virus vaccination to prevent cervical cancer at college of medicine and health sciences University of Gondar. Northwest Ethiopia BMC Res Notes. 2019;12:58.","journal-title":"Northwest Ethiopia BMC Res Notes"},{"key":"5268_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4314\/jcmphc.v33i2.1","volume":"33","author":"PA Akinyemi","year":"2021","unstructured":"Akinyemi PA, Owoade IA, Fajobi O, Wuraola FO, Elugbaju OT. Determinants of willingness to pay for COVID-19 vaccines among residents of Osun State, South-West Nigeria. J Community Med Prim Health Care. 2021;33:1\u201318.","journal-title":"J Community Med Prim Health Care"},{"key":"5268_CR30","volume-title":"Global technical strategy for malaria 2016\u20132030","author":"World Health Organization","year":"2021","unstructured":"World Health Organization. Global technical strategy for malaria 2016\u20132030. Geneva: World Health Organization; 2021."}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05268-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-025-05268-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05268-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T03:26:07Z","timestamp":1738898767000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-025-05268-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5268"],"URL":"https:\/\/doi.org\/10.1186\/s12936-025-05268-y","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,7]]},"assertion":[{"value":"27 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Prior to the commencement of data collection, ethical approval was obtained from the National Institute for Pharmaceutical Research and Development Health Research Ethics Committee with Approval Number: NHREC\/039\/21A. Participation in the study was voluntary. Written informed consent was obtained from the respondents prior to the administration of the questionnaires. All information provided was treated with absolute confidentiality.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36"}}